Mar 22 | Mar 21 | Mar 20 | Mar 19 | Mar 16 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 851.00M | $ 133.80M | $ 712.00M | $ 396.76M | $ 775.50M |
Total Assets | $ 9.85B | $ 9.54B | $ 7.40B | $ 6.45B | $ 6.63B |
Total Debt | $ 3.68B | $ 3.61B | $ 3.40B | $ 2.97B | $ 2.60B |
Net Debt | $ 2.83B | $ 3.48B | $ 2.68B | $ 2.57B | $ 1.82B |
Total Liabilities | $ 4.71B | $ 5.45B | $ 4.14B | $ 3.82B | $ 3.56B |
Stockholders Equity | $ 3.71B | $ 2.64B | $ 2.08B | $ 1.58B | $ 1.92B |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |